Reach out to your doctor to learn more about your treatment options.
Cabenuva Could Potentially Help Prevent HIV
Cabenuva consists of cabotegravir and rilpivirine.
However, he expects that ViiV Healthcare will file for approval of this treatment relatively soon.
Karl Tapales / Getty Images
The FDA has tried to be very responsive to HIV," Volberding says.
“Partly, this is due to activist pressure.
The federal agency approved Vocabria, an oral (tablet) formulation of cabotegravir, along with Cabenuva.
The most obvious, perhaps, is the ease of adherence.
There can also be psychological comfort in medicating less rather than more.
As Appelbaum points out, there is still a social stigma associated with being HIV-positive.
Since receiving FDA approval, ViiV Healthcare will apply for a change to Cabenuvas label.
The change would mean patients only have to receive six shots a year, compared to 12.
U.S. Food and Drug Administration.FDA approves first extended-release, injectable drug regimen for adults living with HIV.
Jones A.Types of antiretroviral medications.
ViiV Healthcare.ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women.
